MediWound Ltd. SEC filings MDWD
MediWound Ltd. has 397 filings in SEC EDGAR's recent list, going back to Dec 23, 2013. Its latest annual report, Form 20-F, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Nov 5, 2026 | — |
| FWP | Free writing prospectus | Nov 3, 2026 | — |
| 424B5 | Prospectus supplement | Nov 3, 2026 | — |
| S-8 | Employee stock plan registration | Mar 5, 2026 | — |
| 424B5 | Prospectus supplement | Sep 30, 2025 | — |
| 424B3 | Prospectus | Mar 28, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 19, 2025 | — |
| S-8 | Employee stock plan registration | Mar 19, 2025 | — |
| 424B3 | Prospectus | Sep 9, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 29, 2024 | — |
| S-8 | Employee stock plan registration | Aug 15, 2023 | — |
| 424B3 | Prospectus | Apr 6, 2023 | — |
| POS AM | Filing | Mar 31, 2023 | — |
| 424B3 | Prospectus | Mar 16, 2023 | — |
| 424B3 | Prospectus | Mar 16, 2023 | — |
| 424B5 | Prospectus supplement | Feb 3, 2023 | — |
| 424B3 | Prospectus | Jan 9, 2023 | — |
| 424B3 | Prospectus | Jan 6, 2023 | — |
| 424B3 | Prospectus | Nov 25, 2022 | — |
| F-1 | Registration statement (foreign issuer) | Nov 10, 2022 | — |
| 424B5 | Prospectus supplement | Sep 22, 2022 | — |
| S-8 | Employee stock plan registration | Aug 9, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | May 25, 2022 | — |
| 424B5 | Prospectus supplement | Mar 3, 2022 | — |
| 424B3 | Prospectus | Mar 2, 2022 | — |
| S-8 | Employee stock plan registration | May 5, 2021 | — |
| 424B3 | Prospectus | Mar 22, 2021 | — |
| S-8 | Employee stock plan registration | Feb 25, 2020 | — |
| 424B5 | Prospectus supplement | Feb 25, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 25, 2019 | — |
| S-8 | Employee stock plan registration | Mar 25, 2019 | — |
| S-8 | Employee stock plan registration | Mar 19, 2018 | — |
| 424B5 | Prospectus supplement | Sep 19, 2017 | — |
| 424B5 | Prospectus supplement | Sep 18, 2017 | — |
| S-8 | Employee stock plan registration | Mar 24, 2016 | — |
| F-3 | Shelf registration (foreign issuer) | Jan 25, 2016 | — |
| S-8 | Employee stock plan registration | Apr 28, 2014 | — |
| 424B4 | Prospectus | Mar 21, 2014 | — |
| F-1/A | Filing | Mar 14, 2014 | — |
| F-1/A | Filing | Mar 3, 2014 | — |
| F-1/A | Filing | Feb 18, 2014 | — |
| F-1 | Registration statement (foreign issuer) | Feb 10, 2014 | — |
Showing 42 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- MDWD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Yavne, Israel
- SEC filer status
- Accelerated filer
- SEC CIK
- 1593984
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.